Lumizyme Lyophilisate For Solution For Injection 52.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Lumizyme: Lyophilisate for solution for injection (52.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ALGLUCOSIDASE ALFA (al glu KO si das AL fa) is a drug that is used to replace an enzyme that is missing in patients with Pompe disease. It is not a cure.

In-Depth Information

Lumizyme 50mg Powder for Injection

NDC: 584680160
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Acid Alpha-glucosidase Deficiency (Pompe Disease)

Storage Information
Refrigerate (between 36 and 46 degrees F)
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Diluted product if not used immediately can be stored at 36 to 46 degrees F for up to 24 hours
Do not freeze
Discard unused portion. Do not store for later use.
Lumizyme 50mg Powder for Injection

Reported Side Effects for Lumizyme 50mg Powder for Injection

Loose Stools Incidence:
<62.0%*
Severity: MILD
Onset: EARLY
Severe Allergy Incidence:
1.0-7.0%*
Severity: SEVERE
Onset: RAPID
Suddenly Stopped Heart Incidence:
1.0%*
Severity: SEVERE
Onset: EARLY
Fluid Retention Incidence:
3.0%*
Severity: MODERATE
Onset: DELAYED
Rhinitis Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Feeling Sick Incidence:
6.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
6.0-7.0%*
Severity: MODERATE
Onset: EARLY
Hives Incidence:
8.0-21.0%*
Severity: MILD
Onset: RAPID
Rapid Heart Rate Incidence:
8.0-23.0%*
Severity: MODERATE
Onset: RAPID
Sore Throat Incidence:
9.0-36.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
15.0%*
Severity: MILD
Onset: EARLY
Slow Heart Beat Incidence:
21.0%*
Severity: SEVERE
Onset: RAPID
Constipation Incidence:
23.0%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
26.0%*
Severity: MILD
Onset: DELAYED
Runny Nose Incidence:
28.0%*
Severity: MILD
Onset: EARLY
Yeast Infection Incidence:
31.0%*
Severity: MODERATE
Onset: DELAYED
Anemia Incidence:
31.0%*
Severity: MODERATE
Onset: DELAYED
Diaper Rash Incidence:
36.0%*
Severity: MILD
Onset: DELAYED
Antibody Formation Incidence:
89.0-99.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Lumizyme

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5